Search clinical trials for: C04.557.337.539.522
Total 1 results
-
Heinrich-Heine University, DuesseldorfCelgene CorporationCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, ChronicGermany
Sponsors and Collaborators
- University of Applied Sciences Jena
- Oblikue Consulting
- Gunkang Pharmaceuticals, Inc
- S-Biotek Holding ApS
- United States Department of Defense (DOD)
- Foshan Sanshui District People's Hospital
- Lilly PharmaceuticalCompany
- Paulo Sérgio Gomes Nogueira Borges
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Arsha Vidya Tirtha
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Plethora Solutions Ltd
- Sudimplant SAS - Groupe TBR
- Rivierduinen, Centre for Personality disorders Jelgersma
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Korea Otsuka International Asia Arab
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Eurotrials Brasil Consultores Cientificos Ltda
- Julian Taylor Green
- Iyad Naeem Muhammad, PhD
- View Full List
Medical Conditions
- Advance Directive Completion
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Immunologically-induced Lung Disease
- Puberty, Delayed
- Anemia Acute
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Serum Albumin Low
- Vibration; Exposure
- Deformity Flexion
- Thyroid and Parathyroid Surgery
- Visual Attention Span Deficit
- Huntington Chorea
- Hypothermia Following Anesthesia, Sequela
- Malaria,Falciparum
- Brain Tumor, Primary
- Gray Platelet Syndrome
- Testicular Teratoma
- Blepharospasm of Both Eyelids
- Chemotherapy-Induced Neutropenia
- View Full List
Drug Interventions
- Pegfilgrastim
- Pemetrexed
- ABY-035 i.v.
- Mineralocorticoid receptor antagonist
- Celecoxib
- Cyanoacrylate
- Furmonertinib 160 mg
- Rovalpituzumab tesirine
- Bimatoprost 0.03% eye drops
- Ebselen
- F520
- Sorafenib
- Oxycodone
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Cytisine
- MMV390048 120mg
- Acalabrutinib in combination with VR
- Vosaroxin
- S-Adenosyl-Methionine
- Standard medical therapy
- View Full List
CROs by country
- Contract Research Organizations in Burundi
- Contract Research Organizations in China
- Contract Research Organizations in France
- Contract Research Organizations in Georgia
- Contract Research Organizations in Kenya
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Liberia
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Mali
- Contract Research Organizations in Poland
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Venezuela
- CRO list by country